» Authors » S Caldeira

S Caldeira

Explore the profile of S Caldeira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Romeiro J, Caldeira S, Herdman T, Lopes C, Vieira M
Int Nurs Rev . 2020 Aug; 67(4):562-567. PMID: 32779198
Aim: The aim of this paper is to propose a label structure for nursing diagnosis syndromes from NANDA-I. Background: Worldwide changes and human needs seem to get more complex, offering...
2.
3.
Caldeira S, Timmins F
Int Nurs Rev . 2016 Apr; 63(2):191-9. PMID: 27029400
Aim: To synthetize elements of research on concept analyses of resilience; and to propose a definition of resilience to NANDA International (NANDA-I) and International Classification for Nursing Practice (ICNP(®) )....
4.
Dong W, Caldeira S, Sehr P, Pawlita M, Tommasino M
J Virol Methods . 2001 Sep; 98(1):91-8. PMID: 11543887
A plate-binding assay was developed to quantify the affinity of the E7 oncoprotein from different human papillomavirus (HPV) types for the tumour suppressor pRb. The method is highly reproducible, sensitive...
5.
Osen W, Peiler T, Ohlschlager P, Caldeira S, Faath S, Michel N, et al.
Vaccine . 2001 Jul; 19(30):4276-86. PMID: 11457555
Vaccination with oncogene-derived DNA for anti-cancer treatment carries a risk of de-novo tumor induction triggered by the persisting recombinant DNA. We hypothesized that an oncoprotein whose primary sequence has been...
6.
Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao M, Tommasino M
J Virol . 2001 Apr; 75(10):4705-12. PMID: 11312342
It has previously been shown that the E7 protein from the cutaneous human papillomavirus type 1 (HPV1), which is associated with benign skin lesions, binds the product of the tumor...
7.
Reshkin S, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, et al.
FASEB J . 2000 Oct; 14(14):2185-97. PMID: 11053239
In this study we investigate the mechanism of intracellular pH change and its role in malignant transformation using the E7 oncogene of human papillomavirus type 16 (HPV16). Infecting NIH3T3 cells...
8.
Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarre M, Dell Orco M, et al.
Oncogene . 2000 May; 19(19):2277-85. PMID: 10822378
The HPV16 E7 oncoprotein neutralizes several cell cycle checkpoints, favouring the entry of quiescent cells into S phase. This activity is mediated in part by association of E7 with the...
9.
Caldeira S, de Villiers E, Tommasino M
Oncogene . 2000 Mar; 19(6):821-6. PMID: 10698500
Studies on human papillomavirus type 16 have demonstrated that the product of the early gene, E7, plays a key role in the immortalization and malignant transformation of the host cell....
10.
Caldeira S
Rev Enferm (Lisboa) . 1971 Jul; 18(1):24-8. PMID: 5211519
No abstract available.